Danta Mark相关文献与解析，生知库 | 链接生命科学的每一步

Oral Microbial Diversity is Associated with Biologic Treatment and Metabolic Health Status but not with Disease Activity in Patients with Inflammatory Bowel Disease

口腔微生物多样性与炎症性肠病患者的生物治疗和代谢健康状况相关，但与疾病活动度无关。

期刊:Crohns Colitis 360

影响因子:2.6

doi:10.1093/crocol/otaf047

Wark, Gabrielle; Kaakoush, Nadeem O; Samocha-Bonet, Dorit; Ghaly, Simon; Danta, Mark

Corrigendum to "Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales" [JHEP Reports 4 (2022)]

对“新南威尔士州乙型肝炎报告人群中失代偿性肝硬化和肝细胞癌的趋势”的更正[JHEP Reports 4 (2022)]

期刊:Jhep Reports

影响因子:7.5

doi:10.1016/j.jhepr.2024.101022

Bin Usman Shah, Syed Hassan; Alavi, Maryam; Hajarizadeh, Behzad; Matthews, Gail V; Martinello, Marianne; Danta, Mark; Amin, Janaki; Law, Matthew G; George, Jacob; Valerio, Heather; Dore, Gregory J

Dietary Determinants of Metabolic and Gut Microbial Health in Patients with Inflammatory Bowel Disease

饮食因素对炎症性肠病患者代谢和肠道微生物健康的影响

期刊:Nutrients

影响因子:5

doi:10.3390/nu16193233

Wark, Gabrielle; Kaakoush, Nadeem O; Samocha-Bonet, Dorit; Ghaly, Simon; Danta, Mark

Activation of the kynurenine pathway identified in individuals with covert hepatic encephalopathy

在隐匿性肝性脑病患者中发现犬尿氨酸途径激活

期刊:Hepatology Communications

影响因子:4.6

doi:10.1097/HC9.0000000000000559

Zeng, Georgia; Krishnamurthy, Shivani; Staats Pires, Ananda; Guller, Anna; Chaganti, Joga; Tun, Nway; Lockart, Ian; Montagnese, Sara; Brew, Bruce; Guillemin, Gilles J; Danta, Mark; Heng, Benjamin

神经科学

发表日期：2024

文献求助收藏

Novel magnetic resonance KTRANS measurement of blood-brain barrier permeability correlated with covert HE

新型磁共振KTRANS测量血脑屏障通透性与隐匿性肝性脑病相关

期刊:Hepatology Communications

影响因子:4.6

doi:10.1097/HC9.0000000000000079

Chaganti, Joga; Zeng, Georgia; Tun, Nway; Lockart, Ian; Abdelshaheed, Christina; Cysique, Lucette; Montagnese, Sara; Brew, Bruce J; Danta, Mark

Aspirin, chronic hepatitis B (CHB) and hepatocellular carcinoma (HCC)-will there ever be enough data?

阿司匹林、慢性乙型肝炎（CHB）和肝细胞癌（HCC）——何时才能有足够的数据？

期刊:Annals of Translational Medicine

影响因子:

doi:10.21037/atm-23-205

Crane, Harry; Danta, Mark

HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysis

丙型肝炎治愈后晚期纤维化或肝硬化患者发生肝细胞癌的概率：一项荟萃分析

期刊:Hepatology

影响因子:15.8

doi:10.1002/hep.32341

Lockart, Ian; Yeo, Malcolm G H; Hajarizadeh, Behzad; Dore, Gregory J; Danta, Mark

Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales

新南威尔士州乙型肝炎报告人群中失代偿性肝硬化和肝细胞癌的趋势

期刊:Jhep Reports

影响因子:7.5

doi:10.1016/j.jhepr.2022.100552

Shah, Syed Hassan Bin Usman; Alavi, Maryam; Hajarizadeh, Behzad; Matthews, Gail V; Martinello, Marianne; Danta, Mark; Amin, Janaki; Law, Matthew G; George, Jacob; Valerio, Heather; Dore, Gregory J

Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection.

HIV感染得到控制的患者胃肠道黏膜屏障功能和微生物群的保护

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2021.688886

Mak Gerald, Zaunders John J, Bailey Michelle, Seddiki Nabila, Rogers Geraint, Leong Lex, Phan Tri Giang, Kelleher Anthony D, Koelsch Kersten K, Boyd Mark A, Danta Mark

Understanding the microbiome in autologous haemopoietic stem cell transplant for multiple sclerosis

了解自体造血干细胞移植治疗多发性硬化症中的微生物组

Oral Microbial Diversity is Associated with Biologic Treatment and Metabolic Health Status but not with Disease Activity in Patients with Inflammatory Bowel Disease

口腔微生物多样性与炎症性肠病患者的生物治疗和代谢健康状况相关，但与疾病活动度无关。

Corrigendum to "Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales" [JHEP Reports 4 (2022)]

对“新南威尔士州乙型肝炎报告人群中失代偿性肝硬化和肝细胞癌的趋势”的更正[JHEP Reports 4 (2022)]

Dietary Determinants of Metabolic and Gut Microbial Health in Patients with Inflammatory Bowel Disease

饮食因素对炎症性肠病患者代谢和肠道微生物健康的影响

Activation of the kynurenine pathway identified in individuals with covert hepatic encephalopathy

在隐匿性肝性脑病患者中发现犬尿氨酸途径激活

Novel magnetic resonance KTRANS measurement of blood-brain barrier permeability correlated with covert HE

新型磁共振KTRANS测量血脑屏障通透性与隐匿性肝性脑病相关

Aspirin, chronic hepatitis B (CHB) and hepatocellular carcinoma (HCC)-will there ever be enough data?

阿司匹林、慢性乙型肝炎（CHB）和肝细胞癌（HCC）——何时才能有足够的数据？

HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysis

丙型肝炎治愈后晚期纤维化或肝硬化患者发生肝细胞癌的概率：一项荟萃分析

Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales

新南威尔士州乙型肝炎报告人群中失代偿性肝硬化和肝细胞癌的趋势

Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection.

HIV感染得到控制的患者胃肠道黏膜屏障功能和微生物群的保护